172 related articles for article (PubMed ID: 11602497)
1. Electrophysiological effects of ibutilide in patients with accessory pathways.
Glatter KA; Dorostkar PC; Yang Y; Lee RJ; Van Hare GF; Keung E; Modin G; Scheinman MM
Circulation; 2001 Oct; 104(16):1933-9. PubMed ID: 11602497
[TBL] [Abstract][Full Text] [Related]
2. Ibutilide for termination of atrial fibrillation in the Wolff-Parkinson-White syndrome.
Varriale P; Sedighi A; Mirzaietehrane M
Pacing Clin Electrophysiol; 1999 Aug; 22(8):1267-9. PubMed ID: 10461309
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Nifekalant in Patients With Wolff-Parkinson-White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings.
Hu J; Yu J; Chen Q; Hu J; Huang Q; Xia Z; Xia Z; Ju Z; Yuan P; Fan S; Xiong Q; Zhu B; Huang L; You C; Bao H; Wu Y; Cheng X; Li J; Marian AJ; Hong K
J Am Heart Assoc; 2019 Jul; 8(13):e012511. PubMed ID: 31234695
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic and clinical effects of intravenous and oral encainide in patients with Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation.
Chimienti M; Moizi M; Salerno JA; Klersy C; Guasti L; Previtali M; Marangoni E; Montemartini C; Bobba P
Eur Heart J; 1987 Mar; 8(3):282-90. PubMed ID: 3107987
[TBL] [Abstract][Full Text] [Related]
5. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
Jiang H
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
[TBL] [Abstract][Full Text] [Related]
6. Ethmozin. I. Effects of intravenous drug administration on paroxysmal supraventricular tachycardia in the ventricular preexcitation syndrome.
Chazov EI; Shugushev KK; Rosenshtraukh LV
Am Heart J; 1984 Sep; 108(3 Pt 1):475-82. PubMed ID: 6382988
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathway.
Kunze KP; Kuck KH; Schlüter M; Kuch B; Bleifeld W
Am J Cardiol; 1984 Aug; 54(3):323-9. PubMed ID: 6431796
[TBL] [Abstract][Full Text] [Related]
8. [Effect of heart rate on the refractory period of the accessory atrioventricular pathway in Wolff-Parkinson-White syndrome].
Fromer M; Gloor H; Kappenberger L
Schweiz Med Wochenschr; 1985 Nov; 115(44):1545-51. PubMed ID: 4081683
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
[TBL] [Abstract][Full Text] [Related]
10. The effect of ibutilide on retrograde accessory pathway conduction.
Sorbera C; Cohen M
Pacing Clin Electrophysiol; 2000 Feb; 23(2):220-3. PubMed ID: 10709230
[TBL] [Abstract][Full Text] [Related]
11. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
Prystowsky EN; Klein GJ; Rinkenberger RL; Heger JJ; Naccarelli GV; Zipes DP
Circulation; 1984 Feb; 69(2):278-87. PubMed ID: 6418407
[TBL] [Abstract][Full Text] [Related]
13. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous amiodarone and ibutilide on action potential duration and atrial conduction kinetics in patients with persistent atrial fibrillation.
Sasaki N; Watanabe I; Kogawa R; Sonoda K; Takahashi K; Okumura Y; Ohkubo K; Nakai T; Hirayama A
Int Heart J; 2014; 55(3):244-8. PubMed ID: 24806377
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
Chen SA; Chiang CE; Tai CT; Lee SH; Chiou CW; Ueng KC; Wen ZC; Cheng CC; Chang MS
Circulation; 1996 Jun; 93(11):2023-32. PubMed ID: 8640978
[TBL] [Abstract][Full Text] [Related]
16. Transient appearance of antegrade conduction via an AV accessory pathway caused by atrial fibrillation in a patient with intermittent Wolff-Parkinson-White syndrome.
Niwano S; Kitano Y; Moriguchi M; Izumi T
Heart; 2000 May; 83(5):E8. PubMed ID: 10768920
[TBL] [Abstract][Full Text] [Related]
17. Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome.
Swerdlow CD; Peterson J; Liem LB
Am J Cardiol; 1988 Jul; 62(1):78-82. PubMed ID: 2898208
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic effects of lorcainide on the accessory pathway in the Wolff-Parkinson-White syndrome.
Kasper W; Treese N; Meinertz T; Jähnchen E; Pop T
Am J Cardiol; 1983 Jun; 51(10):1618-22. PubMed ID: 6858867
[TBL] [Abstract][Full Text] [Related]
19. The electrophysiologic effects of volatile anesthetics and sufentanil on the normal atrioventricular conduction system and accessory pathways in Wolff-Parkinson-White syndrome.
Sharpe MD; Dobkowski WB; Murkin JM; Klein G; Guiraudon G; Yee R
Anesthesiology; 1994 Jan; 80(1):63-70. PubMed ID: 8291732
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency catheter ablation of accessory pathways during pre-excited atrial fibrillation: acute success rate and long-term clinical follow-up results as compared to those patients undergoing successful catheter ablation during sinus rhythm.
Kose S; Amasyali B; Aytemir K; Can I; Kilic A; Kursaklioglu H; Iyisoy A; Isik E
Heart Vessels; 2005 Jul; 20(4):142-6. PubMed ID: 16025362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
